Investor Avoro Capital Advisors LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Avoro Capital Advisors LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-14 13G/A BPMC / Blueprint Medicines Corporation 3,850,000 375,000
2025-08-14 13G/A SLNO / Soleno Therapeutics, Inc. 2,181,000 2,050,000
2025-08-14 13G/A GLUE / Monte Rosa Therapeutics, Inc. 4,345,000 3,725,000
2025-08-14 13G/A ARWR / Arrowhead Pharmaceuticals, Inc. 12,028,552 11,517,441
2025-08-14 13G/A TRML / Tourmaline Bio, Inc. 2,222,222 2,555,555
2025-08-14 13G QURE / uniQure N.V. 3,625,000
2025-08-14 13G MLTX / MoonLake Immunotherapeutics 4,150,000
2025-05-15 13G/A BCRX / BioCryst Pharmaceuticals, Inc. 13,050,000 8,700,000
2025-05-15 13G BPMC / Blueprint Medicines Corporation 3,850,000
2025-05-15 13G/A FOLD / Amicus Therapeutics, Inc. 23,175,000 20,500,000
2025-03-04 13D/A WHWK / Whitehawk Therapeutics, Inc. 3,581,961 11,914,961
2025-02-14 13G/A ARWR / Arrowhead Pharmaceuticals, Inc. 8,888,888 12,028,552
2025-02-14 13G/A GLUE / Monte Rosa Therapeutics, Inc. 4,535,000 4,345,000
2025-02-14 13G/A VERA / Vera Therapeutics, Inc. 4,309,590 5,610,000
2024-12-23 13D/A WHWK / Whitehawk Therapeutics, Inc. 3,471,752 3,581,961
2024-11-14 13G TSHA / Taysha Gene Therapies, Inc. 23,094,444
2024-11-14 13G TRML / Tourmaline Bio, Inc. 2,222,222
2024-11-14 13G RNA / Avidity Biosciences, Inc. 9,935,792
2024-11-14 13G ARWR / Arrowhead Pharmaceuticals, Inc. 8,888,888
2024-11-14 13G OCUL / Ocular Therapeutix, Inc. 12,714,874
2024-11-14 13G SLNO / Soleno Therapeutics, Inc. 2,181,000
2024-11-14 13G/A SYRE / Spyre Therapeutics, Inc. 1,839,138 885,059
2024-11-14 13G VERA / Vera Therapeutics, Inc. 4,309,590
2024-11-14 13G/A MRNS / Marinus Pharmaceuticals, Inc. 3,150,000 0
2024-11-14 13G/A VRCA / Verrica Pharmaceuticals Inc. 6,583,332 0
2024-11-14 13G/A GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) 6,999,999 0
2024-11-14 13G/A FOLD / Amicus Therapeutics, Inc. 27,400,000 23,175,000
2024-11-14 13G/A KYMR / Kymera Therapeutics, Inc. 3,775,000 7,750,000
2024-11-14 13G/A ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) 3,755,555 4,988,888
2024-04-23 13G/A SYRE / Spyre Therapeutics, Inc. 2,125,597 1,839,138
2024-02-14 13G/A KRYS / Krystal Biotech, Inc. 1,410,000 2,565,555
2024-02-14 13G/A APLS / Apellis Pharmaceuticals, Inc. 10,625,000 13,411,111
2024-02-14 13G/A FOLD / Amicus Therapeutics, Inc. 26,800,000 27,400,000
2024-02-14 13G/A MDGL / Madrigal Pharmaceuticals, Inc. 1,660,000 2,288,888
2024-02-14 13G/A MRSN / Mersana Therapeutics, Inc. 7,550,000 0
2024-02-14 13G/A PMVP / PMV Pharmaceuticals, Inc. 3,060,000 0
2024-02-14 13G/A ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) 3,100,000 3,755,555
2024-02-14 13G/A KYMR / Kymera Therapeutics, Inc. 3,850,000 3,775,000
2024-02-14 13G/A GLUE / Monte Rosa Therapeutics, Inc. 4,325,000 4,535,000
2024-02-14 13G/A MRTX / Mirati Therapeutics, Inc. 5,555,555 4,886,840
2024-02-14 13G/A XENE / Xenon Pharmaceuticals Inc. 4,900,000 5,666,666
2024-02-14 13G VRCA / Verrica Pharmaceuticals Inc. 6,583,332
2024-02-14 13G/A CBAY / CymaBay Therapeutics, Inc. 12,800,000 16,337,739
2024-02-14 13G SYRE / Spyre Therapeutics, Inc. 2,125,597
2024-02-14 13G GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) 6,999,999
2024-02-14 13G/A UTHR / United Therapeutics Corporation 2,865,000 2,858,888
2024-02-14 13G/A MRNS / Marinus Pharmaceuticals, Inc. 3,150,000 3,150,000
2024-02-14 13G BCRX / BioCryst Pharmaceuticals, Inc. 13,050,000
2024-02-14 13G/A IOBT / IO Biotech, Inc. 2,055,883 0
2023-02-14 13G/A XENE / Xenon Pharmaceuticals Inc. 4,985,000 4,900,000
2023-02-14 13G/A GLUE / Monte Rosa Therapeutics, Inc. 3,311,434 4,325,000
2023-02-14 13G/A MRSN / Mersana Therapeutics, Inc. 6,800,000 7,550,000
2023-02-14 13G KYMR / Kymera Therapeutics, Inc. 3,850,000
2023-02-14 13G/A APLS / Apellis Pharmaceuticals, Inc. 8,555,555 10,625,000
2023-02-14 13G/A ISEE / IVERIC bio Inc 7,250,000 6,750,000
2023-02-14 13G/A MDGL / Madrigal Pharmaceuticals, Inc. 1,425,000 1,660,000
2023-02-14 13G/A FOLD / Amicus Therapeutics, Inc. 18,500,000 26,800,000
2023-02-14 13G/A MRNS / Marinus Pharmaceuticals, Inc. 3,235,000 3,150,000
2023-02-14 13G/A PMVP / PMV Pharmaceuticals, Inc. 1,465,000 3,060,000
2023-02-14 13G KRYS / Krystal Biotech, Inc. 1,410,000
2023-02-14 13G/A MRTX / Mirati Therapeutics, Inc. 5,075,000 5,555,555
2023-02-14 13G/A UTHR / United Therapeutics Corporation 3,035,000 2,865,000
2023-02-14 13G DICE / DICE Therapeutics Inc 2,525,555
2023-02-14 13G/A KURA / Kura Oncology, Inc. 4,000,000 3,105,000
2023-02-14 13G ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) 3,100,000
2023-02-14 13G/A IOVA / Iovance Biotherapeutics, Inc. 8,675,000 7,020,000
2023-02-14 13G/A ADVM / Adverum Biotechnologies, Inc. 6,950,000 0
2022-09-26 13D/A AADI / Aadi Bioscience, Inc. 2,211,752 3,471,752
2022-02-11 13G/A PNT / POINT Biopharma Global Inc. 0
2022-02-11 13G/A FENC / Fennec Pharmaceuticals Inc. 1,670,000 1,200,000
2022-02-11 13G/A RLMD / Relmada Therapeutics, Inc. 1,525,000 0
2022-02-11 13G/A PMVP / PMV Pharmaceuticals, Inc. 2,350,267 1,465,000
2022-02-11 13G/A AVDL / Avadel Pharmaceuticals plc 4,365,000 1,670,000
2022-02-11 13G/A ARNA / Arena Pharmaceuticals Inc 4,190,000 1,235,000
2022-02-11 13G IOBT / IO Biotech, Inc. 2,055,883
2022-02-11 13G FOLD / Amicus Therapeutics, Inc. 11,200,000 18,500,000
2022-02-11 13G GLUE / Monte Rosa Therapeutics, Inc. 3,311,434
2022-02-11 13G/A IOVA / Iovance Biotherapeutics, Inc. 7,500,000 8,675,000
2022-02-11 13G APLS / Apellis Pharmaceuticals, Inc. 8,555,555
2022-02-11 13G/A CBAY / CymaBay Therapeutics, Inc. 10,300,000 12,800,000
2022-02-11 13G/A MDGL / Madrigal Pharmaceuticals, Inc. 1,225,000 1,425,000
2022-02-11 13G/A MRNS / Marinus Pharmaceuticals, Inc. 3,232,142 3,235,000
2022-02-11 13G/A ADVM / Adverum Biotechnologies, Inc. 8,000,000 6,950,000
2022-02-11 13G/A UTHR / United Therapeutics Corporation 2,850,000 3,035,000
2022-02-11 13G/A XENE / Xenon Pharmaceuticals Inc. 2,800,000 4,985,000
2022-02-11 13G/A MRTX / Mirati Therapeutics, Inc. 4,535,000 5,075,000
2021-11-24 13D/A XLRN / Acceleron Pharma Inc 4,476,100 0
2021-10-05 13D XLRN / Acceleron Pharma Inc 4,476,100
2021-08-30 13D/A AADI / Aadi Bioscience, Inc. 4,500,000 2,211,752
2021-06-04 13D AADI / Aadi Bioscience, Inc. 4,500,000
2021-02-12 13G/A MRNS / Marinus Pharmaceuticals, Inc. 10,405,250 3,232,142
2021-02-12 13G/A KPTI / Karyopharm Therapeutics Inc. 5,900,000 0
2021-02-12 13G/A XENE / Xenon Pharmaceuticals Inc. 2,400,000 2,800,000
2021-02-12 13G/A CUE / Cue Biopharma, Inc. 1,870,000 452,500
2021-02-12 13G/A ATNX / Athenex Inc 5,261,437 372,500
2021-02-12 13G/A ALIM / Alimera Sciences, Inc. 415,999 0
2021-02-12 13G PMVP / PMV Pharmaceuticals, Inc. 2,350,267
2021-02-12 13G TRIL / Trillium Therapeutics Inc 5,800,000
2021-02-12 13G / Therapeutics Acquisition Corp. Class A 1,000,000
2021-02-12 13G UTHR / United Therapeutics Corporation 2,850,000
2021-02-12 13G KURA / Kura Oncology, Inc. 4,000,000
2021-02-12 13G AVDL / Avadel Pharmaceuticals plc 4,365,000
2021-02-12 13G ARNA / Arena Pharmaceuticals Inc 4,190,000
2021-02-12 13G RLMD / Relmada Therapeutics, Inc. 1,525,000
2021-02-12 13G MDGL / Madrigal Pharmaceuticals, Inc. 1,225,000
2021-02-12 13G ISEE / IVERIC bio Inc 7,250,000
2021-02-12 13G MRSN / Mersana Therapeutics, Inc. 6,800,000
2021-02-12 13G GNCA / Genocea Biosciences Inc 33,613,444
2021-02-12 13G/A IOVA / Iovance Biotherapeutics, Inc. 8,826,039 7,500,000
2021-02-12 13G/A FENC / Fennec Pharmaceuticals Inc. 1,105,999 1,670,000
2021-02-12 13G/A US2103731061 / Constellation Pharmaceuticals Inc 3,650,000 2,950,000
2021-02-12 13G/A MRTX / Mirati Therapeutics, Inc. 3,913,435 4,535,000
2021-02-12 13G/A ADVM / Adverum Biotechnologies, Inc. 5,250,000 8,000,000
2020-10-23 13D/A IM3 / Immunomedics Inc 21,000,000 0
2020-09-01 13G CBAY / CymaBay Therapeutics, Inc. 5,500,000 10,300,000
2020-02-24 13G/A IOVA / Iovance Biotherapeutics, Inc. 9,565,000 8,826,039
2020-02-14 13G CBAY / CymaBay Therapeutics, Inc. 5,500,000
2020-02-14 13G KPTI / Karyopharm Therapeutics Inc. 5,900,000
2020-02-14 13G/A IL0011177958 / Intec Pharma Ltd 2,500,000 0
2020-02-14 13G CUE / Cue Biopharma, Inc. 1,870,000
2020-02-14 13G/A TGTX / TG Therapeutics, Inc. 4,750,000 1,000,000
2020-02-14 13G MRNS / Marinus Pharmaceuticals, Inc. 10,405,250
2020-02-14 13G/A BDSI / Biodelivery Sciences International 8,614,588 3,000,000
2020-02-14 13G ADVM / Adverum Biotechnologies, Inc. 5,250,000
2020-02-14 13G US2103731061 / Constellation Pharmaceuticals Inc 3,650,000
2020-02-14 13G/A FOLD / Amicus Therapeutics, Inc. 10,125,000 11,200,000
2020-02-14 13G/A MRTX / Mirati Therapeutics, Inc. 3,813,235 3,913,435
2020-02-14 13G/A TLGT / Teligent Inc 5,300,000 0
2020-02-14 13G/A ALIM / Alimera Sciences, Inc. 6,240,000 415,999
2020-02-14 13G/A IOVA / Iovance Biotherapeutics, Inc. 11,000,000 9,565,000
2020-02-14 13G ATNX / Athenex Inc 5,261,437
2019-07-25 13G/A MRTX / Mirati Therapeutics, Inc. 4,798,101 3,813,235
2019-07-01 13D/A / Immunomedics, Inc. 17,714,461 21,000,000
2019-02-14 13G/A ALIM / Alimera Sciences, Inc. 6,241,581 6,240,000
2019-02-14 13G/A FENC / Fennec Pharmaceuticals Inc. 1,105,999 1,105,999
2019-02-14 13G/A IOVA / Iovance Biotherapeutics, Inc. 5,253,450 11,000,000
2019-02-14 13G XENE / Xenon Pharmaceuticals Inc. 2,400,000
2019-02-14 13G/A TLGT / Teligent Inc 5,049,431 5,300,000
2019-02-14 13G BDSI / Biodelivery Sciences International 8,614,588
2019-02-14 13G/A MRTX / Mirati Therapeutics, Inc. 3,748,101 4,798,101
2019-02-14 13G TGTX / TG Therapeutics, Inc. 4,750,000
2019-02-14 13G/A FOLD / Amicus Therapeutics, Inc. 8,763,122 10,125,000
2019-02-14 13G/A IL0011177958 / Intec Pharma Ltd 2,195,705 2,500,000
2018-06-19 13D/A / Immunomedics, Inc. 17,514,461 17,714,461
2018-06-15 13D/A / Immunomedics, Inc. 16,939,461 17,514,461
2018-02-12 13G FOLD / Amicus Therapeutics, Inc. 8,763,122
2018-02-12 13G IL0011177958 / Intec Pharma Ltd 2,195,705
2018-02-12 13G FENC / Fennec Pharmaceuticals Inc. 1,105,999
2018-02-12 13G/A ALIM / Alimera Sciences, Inc. 4,520,643 6,241,581
2018-02-12 13G/A OTLK / Outlook Therapeutics, Inc. 1,301,425 1,922,888
2018-02-12 13G/A IOVA / Iovance Biotherapeutics, Inc. 3,187,607 5,253,450
2018-02-12 13G VIVE / Viveve Medical, Inc. 1,033,276
2018-02-12 13G ASMB / Assembly Biosciences, Inc. 1,068,534
2018-02-12 13G TLGT / Teligent Inc 5,049,431
2018-02-12 13G CBIO / Crescent Biopharma, Inc. 400,000
2017-11-15 13D/A / Immunomedics, Inc. 10,488,076 16,939,461
2017-10-03 13G/A MRTX / Mirati Therapeutics, Inc. 1,545,701 3,748,101
2017-05-09 13D/A / Immunomedics, Inc. 10,488,076 10,488,076
2017-03-17 13D/A / Immunomedics, Inc. 10,488,076 10,488,076
2017-02-15 13D/A / Immunomedics, Inc. 9,564,140 10,488,076
2017-02-09 13G/A IOVA / Iovance Biotherapeutics, Inc. 3,187,607 4,520,643
2017-02-09 13G/A ALIM / Alimera Sciences, Inc. 4,034,488 4,520,643
2017-02-09 13G AGEN / Agenus Inc. 4,750,430
2017-02-09 13G/A MRTX / Mirati Therapeutics, Inc. 1,295,555 1,545,701
2017-02-09 13G/A IOVA / Iovance Biotherapeutics, Inc. 3,187,607 4,520,643
2017-02-09 13G ALIM / Alimera Sciences, Inc. 4,034,488
2017-02-09 13G OTLK / Outlook Therapeutics, Inc. 1,301,425
2016-11-16 13D / Immunomedics, Inc. 9,564,140
2016-02-12 13G IOVA / Iovance Biotherapeutics, Inc. 3,187,607
2016-02-12 13G MRTX / Mirati Therapeutics, Inc. 1,295,555
2016-02-12 13G PTX / Pernix Therapeutics Holdings, Inc. 5,144,916